These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 4214868

  • 21. Further evidence for immune cytolysis by antibody and the first eight components of complement in the absence of C9.
    Tamura N, Shimada A, Chang S.
    Immunology; 1972 Jan; 22(1):131-40. PubMed ID: 5013908
    [Abstract] [Full Text] [Related]

  • 22. Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel.
    Boyle MD, Langone JJ, Borsos T.
    J Immunol; 1978 May; 120(5):1721-25. PubMed ID: 659873
    [Abstract] [Full Text] [Related]

  • 23. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE, Frank MM.
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract] [Full Text] [Related]

  • 24. Deviated lysis (d.l.): III. Kinetics of interaction of d.l. activity with chicken erythrocytes: evidence for E formation.
    Borsos T, Rother U.
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):36-47. PubMed ID: 405812
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release.
    Gee AP, Boyle MD, Borsos T.
    J Immunol; 1980 Apr; 124(4):1905-10. PubMed ID: 7365242
    [Abstract] [Full Text] [Related]

  • 27. Differentiation of binding from complete activation by use of heterologous components of complement.
    Koethe SM, Austen KF, Gigli I.
    J Immunol; 1972 Apr; 108(4):1063-72. PubMed ID: 5023166
    [No Abstract] [Full Text] [Related]

  • 28. Hemolytic behavior of sheep erythrocytes non-specifically coupled with human Cla.
    Inai S, Tsuyuguchi I.
    Biken J; 1969 Mar; 12(1):1-7. PubMed ID: 4980388
    [No Abstract] [Full Text] [Related]

  • 29. The ninth component of human complement: isolation, description and mode of action.
    Hadding U, Müller-Eberhard HJ.
    Immunology; 1969 Jun; 16(6):719-35. PubMed ID: 4182367
    [Abstract] [Full Text] [Related]

  • 30. Anti-complement effects of two anti-inflammatory agents. Niflumic and flufenamic acids.
    Harrity TW, Goldlust MB.
    Biochem Pharmacol; 1974 Nov 15; 23(22):3107-20. PubMed ID: 4216354
    [No Abstract] [Full Text] [Related]

  • 31. The first component of human complement (C1): kinetics of reaction with its natural substrates.
    Strunk R, Colten HR.
    J Immunol; 1974 Mar 15; 112(3):905-10. PubMed ID: 4811969
    [No Abstract] [Full Text] [Related]

  • 32. Complement: effects of C1 binding affinity on the efficiency of the C2 reaction.
    Linscott WD.
    J Immunol; 1972 Dec 15; 109(6):1327-36. PubMed ID: 4673616
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Preparation and partial characterization of sheep erythrocyte-antibody-complement intermediate.
    Rommel FA, Stolfi R.
    Immunology; 1968 Oct 15; 15(4):469-79. PubMed ID: 5696260
    [Abstract] [Full Text] [Related]

  • 35. [Structure and function of the complement system].
    Klein P.
    Bibl Haematol; 1967 Oct 15; 27():62-80. PubMed ID: 5627947
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4.
    Opferkuch W, Rapp HJ, Colten HR, Borsos T.
    J Immunol; 1971 Apr 15; 106(4):927-31. PubMed ID: 4995006
    [No Abstract] [Full Text] [Related]

  • 39. [Kinetic method of titrating hemolytic antibodies].
    Arapova OIu, Shkurko VI.
    Lab Delo; 1981 Apr 15; (3):176-8. PubMed ID: 6164839
    [No Abstract] [Full Text] [Related]

  • 40. Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5.
    Bitter-Suermann D, Hadding U, Melchert F, Wellensiek HJ.
    Immunochemistry; 1970 Dec 15; 7(12):955-65. PubMed ID: 5503627
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.